Citrate-based dialysate chemical formulations
View Patent ↗The present invention constitutes dialysate formulations that are suitable for use in preparing dialysate solutions for use in batch and/or proportioning systems and for improving dialysis efficiency by reducing or preventing clotting of the dialysis flow paths. The dialysate chemical formulations for one batch of dialysate comprise an acid concentrate stored in a first vessel, and a citrate-containing bicarbonate concentrate stored in a second vessel. The contents of the first and second vessels are emptied into a dialysate preparation tank and mixed with water to form a batch quantity of dialysate solution. Alternately, a dry acid and/or a dry citrate-containing base concentrates are dissolved separately in measured quantities of water to form liquid concentrates which are then used in conjunction with a proportioning machine to generate on-line a final dialysis solution stream.
1. A base concentrate comprising:
(a) sodium bicarbonate;
(b) sodium citrate; and
(c) sodium chloride, wherein the sodium bicarbonate and sodium citrate are present in molar ratio ranging from 50:1 to 15:8, wherein sodium chloride is present in an amount sufficient to provide a sodium concentration ranging from 125 to 150 mEq/L in a final dialysate solution when the base concentrate and an acid concentrate are mixed in a prescribed volume of water, and wherein a sodium contribution of the acid concentrate to the dialysate solution ranges from 10 to 20 mEq/L.
2. A dialysis base concentrate comprising:
(a) bicarbonate in an amount sufficient to provide, in the final dialysate, a concentration ranging from about 15 to 50 mEq/L;
(b) sodium in an amount sufficient to provide, in the final dialysate, a concentration ranging from about 100 to 150 mEq/L;
(c) chloride in an amount sufficient to provide, in the final dialysate, a concentration ranging from about 80 to 130 mEq/L; and
(d) citrate in an amount sufficient to provide, in the final dialysate, a concentration ranging from about 1 to 8 mEq/L;
wherein the base concentrate upon mixing with an acid concentrate and a prescribed volume of water forms a final volume of a dialysis solution, wherein the base concentrate and the acid concentrate are contained in separate vessels and wherein a sodium contribution of the acid concentrate to the dialysis solution ranges from 10 to 20 mEq/L.
3. The base concentrate of claim 2 wherein said citrate is selected from the group consisting of citric acid, a salt of citrate anion, and a partial ester of citrate anion.
4. The base concentrate of claim 2 wherein said citrate is trisodium citrate, disodium hydrogen citrate or monosodium dihydrogen citrate.
5. The base concentrate of claim 4 wherein the base concentrate is contained in a vessel for preparation of a batch of dialysis solution for treatment of single or multiple patients or for a proportioning system for treatment of single or multiple patients, said base concentrate comprising sodium citrate, sodium bicarbonate, and sodium chloride.
6. The base concentrate of claim 2 wherein said citrate is in an amount sufficient to provide, in the final dialysate, a concentration ranging from about 2.5 to 4 mEq/L; sodium in an amount sufficient to provide, in the final dialysate, a concentration ranging from about 123 to 127 mEq/L; and bicarbonate is present in an amount ranging from 30 to 36.5 mEq/L.
7. The base concentrate of claim 2 comprising
(a) bicarbonate in sufficient amount to provide about 36.5 mEq/L in the final dialysate;
(b) sodium in sufficient amount to provide about 127 mEq/L in the final dialysate;
(c) chloride in sufficient amount to provide about 88 mEq/L in the final dialysate; and
(d) citrate in sufficient amount to provide about 2.5 mEq/L in the final dialysate.
8. The base concentrate of claim 2 comprising
(a) bicarbonate in sufficient amount to provide about 31.5 mEq/L in the final dialysate;
(b) sodium in sufficient amount to provide about 123 mEq/L in the final dialysate;
(c) chloride in sufficient amount to provide about 89 mEq/L in the final dialysate; and
(d) citrate in sufficient amount to provide about 2.5 mEq/L in the final dialysate.
9. The base concentrate of claim 2 comprising
(a) bicarbonate in sufficient amount to provide about 36.5 mEq/L in the final dialysate;
(b) sodium in sufficient amount to provide about 123 mEq/L in the final dialysate;
(c) chloride in sufficient amount to provide about 84 mEq/L in the final dialysate; and
(d) citrate in sufficient amount to provide about 2.5 mEq/L in the final dialysate.
10. The base concentrate of claim 2 comprising
(a) bicarbonate in sufficient amount to provide about 35 mEq/L in the final dialysate;
(b) sodium in sufficient amount to provide about 127 mEq/L in the final dialysate;
(c) chloride in sufficient amount to provide about 88 mEq/L in the final dialysate; and
(d) citrate in sufficient amount to provide about 4 mEq/L in the final dialysate.
11. The base concentrate of claim 2 comprising
(a) bicarbonate in sufficient amount to provide about 30.0 mEq/L in the final dialysate;
(b) sodium in sufficient amount to provide about 123 mEq/L in the final dialysate;
(c) chloride in sufficient amount to provide about 89 mEq/L in the final dialysate; and
(d) citrate in sufficient amount to provide about 4 mEq/L in the final dialysate.
12. The base concentrate of claim 2 comprising
(a) bicarbonate in sufficient amount to provide about 35 mEq/L in the final dialysate;
(b) sodium in sufficient amount to provide about 123 mEq/L in the final dialysate;
(c) chloride in sufficient amount to provide about 84 mEq/L in the final dialysate; and
(d) citrate in sufficient amount to provide about 4 mEq/L in the final dialysate.
13. The base concentrate of claim 2 wherein said citrate is citric acid and said citric acid is separated from said bicarbonate.
14. The base concentrate of claim 13 wherein the concentrate is dry and is contained in a vessel for preparation of a batch of dialysis solution for treatment of single or multiple patients or for a proportioning system for treatment of single or multiple patients, said salt is present as a layer deposited in the vessel between said citric acid and said bicarbonate.
15. The base concentrate of claim 13 wherein said citric acid entity in the base concentrate is in tablet or pellet form.
16. The base concentrate of claim 15 wherein the tablet or pellet form is coated with dextrose or sodium chloride.
17. The base concentrate of claim 2 wherein the dialysis base concentrate is used to prepare a hemodialysis concentrate solution.